4 completed, 1 active not recruiting, 1 not yet recruiting. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Active not recruiting 1, Not yet recruiting 1 |
Follow Gout Chronic: new trials by email Literature Review of Gout Chronic trials Research Report on Gout Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients AR882 75 mg, XOI Low Dose, XOI High Dose - Gout, Gouty Arthritis | Phase 2 | Active not recruiting | Arthrosi Therapeutics | 15 | 2025-12-03 | 2026-05-15 |
| Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In Gout Discontibuation of oral ULT, Maintenance of ULT - Gout Chronic | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 450 | 2025-05-01 | 2025-05-04 |
| Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout AR882 Dose 1, AR882 Dose 2, Allopurinol Tablet - Gout, Arthritis, Gouty | Phase 2 | Completed | Arthrosi Therapeutics | 42 | 2022-08-12 | 2025-01-29 |
| Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients AR882 Dose 1, AR882 Dose 2, Placebo - Gout, Arthritis, Gouty | Phase 2 | Completed | Arthrosi Therapeutics | 140 | 2021-11-16 | 2023-05-12 |
| REduCing Immunogenicity to PegloticasE (RECIPE) Study Pegloticase 8 MG/ML [Krystexxa], MMF, Placebo - Gout Chronic | Phase 2 | Completed | University of Alabama at Birmingham | 35 | 2018-06-14 | 2022-03-16 |
| Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid SEL-212, SEL-037, SVP-rapamycin (SEL-110) - Gout Chronic, Hyperuricemia | Phase 2 | Completed | Selecta Biosciences, Inc. | 152 | 2016-10-01 | 2022-02-14 |
Hyperuricemia (4) · Arthritis, Gouty (3) · Gout (3)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Arthritis (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Crystal Arthropathies (3) · Genetic Diseases, Inborn (3) · Joint Diseases (3) · Metabolic Diseases (3) · Metabolism, Inborn Errors (3) · Musculoskeletal Diseases (3) · Nutritional and Metabolic Diseases (3) · Purine-Pyrimidine Metabolism, Inborn Errors (3) · Rheumatic Diseases (3)
Allopurinol (1) · Pegloticase (1)
Arthrosi Therapeutics (3) · Assistance Publique - Hôpitaux de Paris (1) · Selecta Biosciences, Inc. (1) · University of Alabama at Birmingham (1)
United States (5) · Taiwan (2) · Australia (1) · New Zealand (1)
R Keenan, MD (2) · Kenneth G Saag, MD (1) · Robert Keenan, MD (1)